| ŠEDA, Václav, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER a Marek MRÁZ. GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors. In XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL). 2021. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1830661,
author = {Šeda, Václav and Hoferková, Eva and Ondrišová, Laura and Košťálová, Lenka and Sharma, Sonali and Loja, Tomáš and Zicha, Daniel and Verner, Jan and Pospíšilová, Šárka and Brychtová, Yvona and Panovská, Anna and Doubek, Michael and Mayer, Jiří and Mráz, Marek},
booktitle = {XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)},
title = {GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors.},
year = {2021}
}
TY - CONF
ID - 1830661
AU - Šeda, Václav - Hoferková, Eva - Ondrišová, Laura - Košťálová, Lenka - Sharma, Sonali - Loja, Tomáš - Zicha, Daniel - Verner, Jan - Pospíšilová, Šárka - Brychtová, Yvona - Panovská, Anna - Doubek, Michael - Mayer, Jiří - Mráz, Marek
PY - 2021
TI - GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors.
ER -
ŠEDA, Václav, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER a Marek MRÁZ. GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors. In \textit{XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)}. 2021.
|
